CEACAM5 and colorectal carcinoma: Therefore, we limited our study to patients with unresectable CRC with liver metastases who responded poorly to chemotherapy (determined by growing or new liver masses identified by computed tomography or by elevated serum CEA levels) and RFA was included with palliative intent.